BreakingLivTech to acquire Alora Healthcare for $300 billionRead now →

Deal Intelligence

M&A Comparisons (2026)

Side-by-side deal analysis across 50 active acquirers. Compare deal counts, deployed capital, and strategic sector focus — or search for a specific company below.

Comparisons

41

Companies

50

Sectors

19

41 comparisons

All Comparisons

Deep Analysis

Comparison Reports

All reports →
OpenAI
vs
Anthropic

OpenAI vs Anthropic: Who Is Winning the 2026 AI Acquisition Race?

OpenAI and Anthropic are the two most aggressive AI acquirers of 2026. We compare deal counts, capital deployed, target types, and the strategic logic separating the two most powerful AI labs.

5

OpenAI tracked deals

Read →
Blackstone
vs
KKR

Blackstone vs KKR: Private Equity's 2026 Acquisition Showdown

Blackstone and KKR are the two most active private equity firms of 2026. Full side-by-side breakdown of every deal, sector bets, and which firm is positioning better for the next cycle.

0

Tracked deals for Blackstone

Read →
Lilly
vs
Merck

Lilly vs Merck: Side-by-Side Breakdown of 2026 Pharma M&A

Eli Lilly and Merck are racing to dominate pharmaceutical M&A in 2026. We compare deal count, total capital deployed, therapeutic focus, and acquisition strategy to determine who is building the stronger pipeline.

4

Lilly Tracked Deals

Read →
AbbVie
vs
Gilead Sciences

AbbVie vs Gilead: Biotech's Biggest 2026 Acquisition Duel

AbbVie and Gilead Sciences are both hunting for the next blockbuster drug through M&A. A full side-by-side analysis of every 2026 acquisition — deal sizes, therapeutic targets, and strategic divergence.

1

AbbVie Deal Count

Read →
Blue Origin
vs
SpaceX

Blue Origin vs SpaceX: Who Is Acquiring More Aggressively in 2026?

Blue Origin and SpaceX are both expanding through acquisitions in 2026. We compare every deal across the two space giants — capital deployed, strategic targets, and which company is building a more formidable M&A portfolio.

0

Blue Origin tracked deals

Read →
Andreessen Horowitz
vs
General Catalyst

a16z vs General Catalyst: The 2026 VC Acquisition Comparison

Andreessen Horowitz and General Catalyst are two of the most acquisitive venture firms of 2026. We map every deal across AI, healthcare, and fintech to compare which firm is building more strategic M&A positions.

6

Andreessen Horowitz tracked deals

Read →
Acrisure
vs
Gallagher

Acrisure vs Gallagher: Inside the 2026 Insurance Broker Acquisition War

Acrisure and Arthur J. Gallagher are the two most aggressive insurance broker acquirers of 2026. Full deal-by-deal comparison — deal count, geography, premium targets, and who leads the consolidation race.

2

Acrisure tracked deals

Read →
Gallagher
vs
NFP

Gallagher vs NFP: Two Insurance Giants, One M&A Playbook

Arthur J. Gallagher and NFP are both rolling up the insurance brokerage market in 2026. Side-by-side analysis of every acquisition — volume, deal size, and which platform is consolidating faster.

2

Gallagher tracked deals

Read →
Acrisure
vs
NFP

Acrisure vs NFP: Which Insurance Broker Is Acquiring Faster in 2026?

Acrisure and NFP are locked in one of the most aggressive insurance broker acquisition races of 2026. We compare deal counts, capital deployed, and the strategic differences driving each firm's M&A agenda.

2

Acrisure tracked deals

Read →

Browse all acquirer profiles

Deal counts, deployed capital, and full acquisition history for 200+ companies.

View all acquirers →

Get every acquisition in your inbox

FireStrike tracks M&A, IPOs, and fundraises daily — free.

Start tracking free →
FireStrikeFireStrike

Deal intelligence for M&A, mergers, IPOs, and funding rounds — sourced from primary filings and press, updated continuously.

© 2026 FireStrikeEvery deal. Every day.